drugset / Trial / NCT01256541
Kristalose as Bowel Evacuant Prior to Colonoscopy
Phase 1
Completed
20 enrolled
Benaroya Research Institute
Cumberland Pharmaceuticals · collabVirginia Mason Hospital/Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
To determine whether Kristalose causes a significant increase in hydrogen and/or methane gas levels in patients requiring bowel evacuation, and also to determine the safety, efficacy, and patient preference of Kristalose as a bowel evacuant
Timeline
- Start
- 2010-12
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactulose | Other / unclassified | 20 g | — |
Indications
No indication recorded.